Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocard...
Saved in:
| Published in | ESC Heart Failure Vol. 7; no. 1; pp. 253 - 263 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
John Wiley & Sons, Inc
01.02.2020
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2055-5822 2055-5822 |
| DOI | 10.1002/ehf2.12565 |
Cover
| Abstract | Aims
While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV).
Methods and results
We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm2 in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04).
Conclusions
Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. |
|---|---|
| AbstractList | Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV). Methods and results We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm2 in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). Conclusions Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV). Methods and results We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm2 in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). Conclusions Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. AimsWhile right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV).Methods and resultsWe prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm2 in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04).ConclusionsDiffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. While right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH-HFpEF, as measured by cardiovascular magnetic resonance-derived extracellular volume (ECV). We prospectively enrolled participants with PH-HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high-resolution cardiovascular magnetic resonance, and case subjects (PH-HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high-resolution modified look-locker inversion recovery with a 1 × 1 mm in-plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH-HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH-HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH-HFpEF compared with PAH [PH-HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH-HFpEF was associated with worse indices of RV structure (RV end-diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). Diffuse RV fibrosis, as measured by ECV, is present in PH-HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH-HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. While right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH-HFpEF, as measured by cardiovascular magnetic resonance-derived extracellular volume (ECV).AIMSWhile right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH-HFpEF, as measured by cardiovascular magnetic resonance-derived extracellular volume (ECV).We prospectively enrolled participants with PH-HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high-resolution cardiovascular magnetic resonance, and case subjects (PH-HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high-resolution modified look-locker inversion recovery with a 1 × 1 mm2 in-plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH-HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH-HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH-HFpEF compared with PAH [PH-HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH-HFpEF was associated with worse indices of RV structure (RV end-diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04).METHODS AND RESULTSWe prospectively enrolled participants with PH-HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high-resolution cardiovascular magnetic resonance, and case subjects (PH-HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high-resolution modified look-locker inversion recovery with a 1 × 1 mm2 in-plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH-HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH-HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH-HFpEF compared with PAH [PH-HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH-HFpEF was associated with worse indices of RV structure (RV end-diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04).Diffuse RV fibrosis, as measured by ECV, is present in PH-HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH-HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload.CONCLUSIONSDiffuse RV fibrosis, as measured by ECV, is present in PH-HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH-HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. Abstract Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH‐HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV). Methods and results We prospectively enrolled participants with PH‐HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high‐resolution cardiovascular magnetic resonance, and case subjects (PH‐HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high‐resolution modified look‐locker inversion recovery with a 1 × 1 mm2 in‐plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH‐HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH‐HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH‐HFpEF compared with PAH [PH‐HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH‐HFpEF was associated with worse indices of RV structure (RV end‐diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). Conclusions Diffuse RV fibrosis, as measured by ECV, is present in PH‐HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH‐HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload. |
| Author | Carr, James C. Swat, Stanley A. Benefield, Brandon C. Li, Emily Shah, Sanjiv J. Markl, Michael Freed, Benjamin H. Patel, Ravi B. Collins, Jeremy D. Polsinelli, Vincenzo B. |
| AuthorAffiliation | 1 Division of Cardiology Northwestern University Chicago IL USA 5 Department of Radiology, Mayo Clinic Rochester MN USA 4 Department of Biomedical Engineering Northwestern University Chicago IL USA 2 Feinberg Cardiovascular and Renal Research Institute Northwestern University Chicago IL USA 3 Department of Radiology Northwestern University Chicago IL USA |
| AuthorAffiliation_xml | – name: 4 Department of Biomedical Engineering Northwestern University Chicago IL USA – name: 5 Department of Radiology, Mayo Clinic Rochester MN USA – name: 2 Feinberg Cardiovascular and Renal Research Institute Northwestern University Chicago IL USA – name: 3 Department of Radiology Northwestern University Chicago IL USA – name: 1 Division of Cardiology Northwestern University Chicago IL USA |
| Author_xml | – sequence: 1 givenname: Ravi B. surname: Patel fullname: Patel, Ravi B. organization: Northwestern University – sequence: 2 givenname: Emily surname: Li fullname: Li, Emily organization: Northwestern University – sequence: 3 givenname: Brandon C. surname: Benefield fullname: Benefield, Brandon C. organization: Northwestern University – sequence: 4 givenname: Stanley A. surname: Swat fullname: Swat, Stanley A. organization: Northwestern University – sequence: 5 givenname: Vincenzo B. surname: Polsinelli fullname: Polsinelli, Vincenzo B. organization: Northwestern University – sequence: 6 givenname: James C. surname: Carr fullname: Carr, James C. organization: Northwestern University – sequence: 7 givenname: Sanjiv J. surname: Shah fullname: Shah, Sanjiv J. organization: Northwestern University – sequence: 8 givenname: Michael surname: Markl fullname: Markl, Michael organization: Northwestern University – sequence: 9 givenname: Jeremy D. surname: Collins fullname: Collins, Jeremy D. organization: Department of Radiology, Mayo Clinic – sequence: 10 givenname: Benjamin H. surname: Freed fullname: Freed, Benjamin H. email: benjamin.freed@northwestern.edu organization: Northwestern University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31903694$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1rGzEQhpeS0qRpLv0BRdBLKTjVx2plXQolzRcEemnPYqwdeWXWkivtOvjfV84mIQklJw2aZ17e-XhfHYQYsKo-MnrKKOXfsHP8lHHZyDfVEadSzuSc84Mn8WF1kvOKUspkwySv31WHgmkqGl0fVfGnd27MSJJfdgPZYhiSt2MPiTi_SDH7THwgHUIaiAPfjwnJrR86skmYMW2xJbhCO_gYiEswBRBashn7dQyQdqTbbTANGHJJfajeOugznty_x9Wfi_PfZ1ezm1-X12c_bmZWKipnwJSurWq0klC3DBpArRkyia5GlBo4o4Iqt2iU1QoaROYcUiE0qrlorDiurifdNsLKbJJfFycmgjd3HzEtTenI2x4NFGW5cCBUI-syUuAI2uqat4JTKudF6_uktRkXa2ztfkbQPxN9ngm-M8u4NYrOhaSsCHy5F0jx74h5MGufLfY9BIxjNlwU41xptUc_v0BXcUyhjMrwWta1YmUmr1JC6WbOClyoT099Pxp-2H4B6ATYsuic0BnrB9hvsLThe8Oo2d-Y2d-YubuxUvL1RcmD6n9hNsG3vsfdK6Q5v7rgU80_RFfhDw |
| CitedBy_id | crossref_primary_10_1186_s12968_020_00694_0 crossref_primary_10_1007_s12410_020_09550_2 crossref_primary_10_3389_fcvm_2022_758975 crossref_primary_10_3390_diagnostics13010071 crossref_primary_10_3389_fphar_2020_607384 crossref_primary_10_1007_s10554_022_02622_y crossref_primary_10_1016_j_echo_2021_03_017 crossref_primary_10_1007_s10974_023_09651_7 crossref_primary_10_1007_s12265_022_10264_7 crossref_primary_10_1038_s41598_021_96630_y crossref_primary_10_1016_j_ejrad_2022_110386 crossref_primary_10_1152_japplphysiol_00204_2021 crossref_primary_10_1161_CIRCIMAGING_120_011337 crossref_primary_10_1080_14796678_2025_2460909 crossref_primary_10_1161_CIRCRESAHA_121_319900 crossref_primary_10_1007_s10741_020_09998_w crossref_primary_10_3390_jcm13154481 crossref_primary_10_1007_s00259_021_05577_9 crossref_primary_10_1002_ehf2_13514 crossref_primary_10_1161_JAHA_124_034363 crossref_primary_10_3389_fcvm_2022_787656 crossref_primary_10_3390_brainsci12030331 crossref_primary_10_1016_j_pharmthera_2023_108389 crossref_primary_10_1007_s10554_020_01953_y crossref_primary_10_1161_CIRCHEARTFAILURE_120_007840 |
| Cites_doi | 10.1007/s10554-017-1113-3 10.1016/j.jacc.2016.02.018 10.1186/s12968-015-0209-y 10.1161/CIRCHEARTFAILURE.113.000854 10.1002/ejhf.630 10.1161/CIRCULATIONAHA.113.001873 10.1161/CIRCULATIONAHA.109.930636 10.1002/mrm.25100 10.1186/1532-429X-15-92 10.1016/j.jcmg.2012.04.006 10.1093/cvr/cvp002 10.1161/CIRCULATIONAHA.113.008461 10.1002/ejhf.418 10.1056/NEJM197112232852601 10.1161/CIRCULATIONAHA.111.051540 10.1093/eurheartj/ehu193 10.1016/j.jacc.2008.11.051 10.1007/s10554-013-0326-3 10.1002/ejhf.1029 10.1152/ajpheart.00843.2013 10.1186/1532-429X-14-63 10.1002/mrm.20110 10.1007/s11897-015-0267-3 |
| ContentType | Journal Article |
| Copyright | 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology – notice: 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. – notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1002/ehf2.12565 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | RV diffuse interstitial fibrosis in HFpEF |
| EISSN | 2055-5822 |
| EndPage | 263 |
| ExternalDocumentID | oai_doaj_org_article_a9915bfa37654002a2ea9c942d320058 PMC7083501 31903694 10_1002_ehf2_12565 EHF212565 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Feinberg School of Medicine funderid: Eleanor Wood‐Prince Grants Initiative – fundername: National Institutes of Health Grants funderid: R01 HL140731; R01 HL127028; R01 HL105755 – fundername: International Society for Heart and Lung Transplantation funderid: Pulmonary Hypertension Research Award – fundername: American Heart Association Grants funderid: 15CVGPSD27260148; 16SFRN28780016 – fundername: National Heart, Lung, and Blood Institute funderid: T32HL069771 – fundername: NHLBI NIH HHS grantid: R01 HL127028 – fundername: American Heart Association Grants grantid: 15CVGPSD27260148 – fundername: National Institutes of Health Grants grantid: R01 HL105755 – fundername: NHLBI NIH HHS grantid: T32 HL007822 – fundername: American Heart Association Grants grantid: 16SFRN28780016 – fundername: NHLBI NIH HHS grantid: R01 HL140731 – fundername: NHLBI NIH HHS grantid: T32 HL069771 – fundername: ; grantid: T32HL069771 – fundername: ; grantid: Eleanor Wood‐Prince Grants Initiative – fundername: National Institutes of Health Grants grantid: R01 HL140731; R01 HL127028; R01 HL105755 – fundername: American Heart Association Grants grantid: 15CVGPSD27260148; 16SFRN28780016 – fundername: ; grantid: Pulmonary Hypertension Research Award |
| GroupedDBID | 0R~ 1OC 24P 53G 5VS 7X7 8FI 8FJ AAHHS ABUWG ACCFJ ACCMX ACXQS ADBBV ADKYN ADZMN ADZOD AEEZP AEQDE AFKRA AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD EMOBN FYUFA GODZA GROUPED_DOAJ HMCUK HYE IAO IHR INH ITC KQ8 M~E OK1 PIMPY PQQKQ PROAC RPM UKHRP WIN AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c5705-a1794c76975a4d1a6ae991e15ef4ee59a210307fb67c97a6ee1ffe0339e7836c3 |
| IEDL.DBID | 7X7 |
| ISSN | 2055-5822 |
| IngestDate | Wed Aug 27 01:28:44 EDT 2025 Thu Aug 21 14:14:10 EDT 2025 Fri Sep 05 02:56:30 EDT 2025 Fri Jul 25 03:49:40 EDT 2025 Wed Aug 13 11:03:12 EDT 2025 Wed Feb 19 02:28:01 EST 2025 Tue Jul 01 01:34:51 EDT 2025 Thu Apr 24 23:08:14 EDT 2025 Wed Jan 22 16:36:21 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Heart failure with preserved ejection fraction Right ventricle Pulmonary hypertension Cardiac magnetic resonance Fibrosis |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5705-a1794c76975a4d1a6ae991e15ef4ee59a210307fb67c97a6ee1ffe0339e7836c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2454471697?pq-origsite=%requestingapplication% |
| PMID | 31903694 |
| PQID | 2379681245 |
| PQPubID | 4368362 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a9915bfa37654002a2ea9c942d320058 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7083501 proquest_miscellaneous_2333927971 proquest_journals_2454471697 proquest_journals_2379681245 pubmed_primary_31903694 crossref_citationtrail_10_1002_ehf2_12565 crossref_primary_10_1002_ehf2_12565 wiley_primary_10_1002_ehf2_12565_EHF212565 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | February 2020 |
| PublicationDateYYYYMMDD | 2020-02-01 |
| PublicationDate_xml | – month: 02 year: 2020 text: February 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
| PublicationTitle | ESC Heart Failure |
| PublicationTitleAlternate | ESC Heart Fail |
| PublicationYear | 2020 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2015; 12 2004; 52 2015; 17 2013; 14 2014; 307 2009; 53 2015; 73 2009; 82 2013; 128 2010; 122 2014; 35 1971; 285 2016; 18 2012; 14 2018; 34 2014; 30 2012; 125 2014; 130 2014; 7 2012; 5 2018; 20 2016; 67 e_1_2_9_20_1 e_1_2_9_11_1 e_1_2_9_22_1 e_1_2_9_10_1 e_1_2_9_21_1 e_1_2_9_13_1 e_1_2_9_24_1 e_1_2_9_12_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 |
| References_xml | – volume: 307 start-page: H361 year: 2014 end-page: H369 article-title: Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload publication-title: Am J Physiol Heart Circ Physiol – volume: 67 start-page: 1815 year: 2016 end-page: 1825 article-title: Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction publication-title: J Am Coll Cardiol – volume: 130 start-page: 2310 year: 2014 end-page: 2320 article-title: Right ventricular function in heart failure with preserved ejection fraction: a community‐based study publication-title: Circulation – volume: 128 start-page: 2016 year: 2013 end-page: 2025 article-title: Right ventricular diastolic impairment in patients with pulmonary arterial hypertension publication-title: Circulation – volume: 82 start-page: 30 year: 2009 end-page: 39 article-title: Chronic inhibition of phosphodiesterase 5 does not prevent pressure‐overload‐induced right‐ventricular remodelling publication-title: Cardiovasc Res – volume: 53 start-page: 1119 year: 2009 end-page: 1126 article-title: Pulmonary hypertension in heart failure with preserved ejection fraction: a community‐based study publication-title: J Am Coll Cardiol – volume: 125 start-page: 289 year: 2012 end-page: 297 article-title: Pulmonary capillary wedge pressure augments right ventricular pulsatile loading publication-title: Circulation – volume: 18 start-page: 1472 year: 2016 end-page: 1487 article-title: Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis publication-title: Eur J Heart Fail – volume: 17 start-page: 110 year: 2015 article-title: Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator‐Gated Look‐Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance publication-title: J Cardiovasc Magn Reson – volume: 5 start-page: 897 year: 2012 end-page: 907 article-title: Quantification of extracellular matrix expansion by CMR in infiltrative heart disease publication-title: JACC Cardiovasc Imaging – volume: 30 start-page: 323 year: 2014 end-page: 328 article-title: In‐vivo assessment of normal T1 values of the right‐ventricular myocardium by cardiac MRI publication-title: Int J Cardiovasc Imaging – volume: 12 start-page: 295 year: 2015 end-page: 301 article-title: Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction publication-title: Curr Heart Fail Rep – volume: 34 start-page: 55 year: 2018 end-page: 65 article-title: Correlation between right ventricular T1 mapping and right ventricular dysfunction in non‐ischemic cardiomyopathy publication-title: Int J Cardiovasc Imaging – volume: 7 start-page: 288 year: 2014 end-page: 299 article-title: Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction publication-title: Circ Heart Fail – volume: 14 start-page: 92 year: 2013 article-title: Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement publication-title: J Cardiovasc Magn Reson – volume: 285 start-page: 1441 year: 1971 end-page: 1446 article-title: The natural history of congestive heart failure: the Framingham study publication-title: N Engl J Med – volume: 73 start-page: 150 year: 2015 end-page: 160 article-title: Accelerated and navigator‐gated look‐locker imaging for cardiac T1 estimation (ANGIE): development and application to T1 mapping of the right ventricle publication-title: Magn Reson Med – volume: 20 start-page: 16 year: 2018 end-page: 37 article-title: Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology publication-title: Eur J Heart Fail – volume: 35 start-page: 3452 year: 2014 end-page: 3462 article-title: Right heart dysfunction in heart failure with preserved ejection fraction publication-title: Eur Heart J – volume: 14 start-page: 63 year: 2012 article-title: Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method publication-title: Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance – volume: 52 start-page: 141 year: 2004 end-page: 146 article-title: Modified look‐locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart publication-title: Magn Reson Med – volume: 122 start-page: 138 year: 2010 end-page: 144 article-title: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans publication-title: Circulation – volume: 18 start-page: 71 year: 2016 end-page: 80 article-title: The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics publication-title: Eur J Heart Fail – ident: e_1_2_9_16_1 doi: 10.1007/s10554-017-1113-3 – ident: e_1_2_9_12_1 doi: 10.1016/j.jacc.2016.02.018 – ident: e_1_2_9_24_1 doi: 10.1186/s12968-015-0209-y – ident: e_1_2_9_3_1 doi: 10.1161/CIRCHEARTFAILURE.113.000854 – ident: e_1_2_9_7_1 doi: 10.1002/ejhf.630 – ident: e_1_2_9_21_1 doi: 10.1161/CIRCULATIONAHA.113.001873 – ident: e_1_2_9_14_1 doi: 10.1161/CIRCULATIONAHA.109.930636 – ident: e_1_2_9_18_1 doi: 10.1002/mrm.25100 – ident: e_1_2_9_11_1 doi: 10.1186/1532-429X-15-92 – ident: e_1_2_9_15_1 doi: 10.1016/j.jcmg.2012.04.006 – ident: e_1_2_9_22_1 doi: 10.1093/cvr/cvp002 – ident: e_1_2_9_2_1 doi: 10.1161/CIRCULATIONAHA.113.008461 – ident: e_1_2_9_5_1 doi: 10.1002/ejhf.418 – ident: e_1_2_9_9_1 doi: 10.1056/NEJM197112232852601 – ident: e_1_2_9_19_1 doi: 10.1161/CIRCULATIONAHA.111.051540 – ident: e_1_2_9_4_1 doi: 10.1093/eurheartj/ehu193 – ident: e_1_2_9_8_1 doi: 10.1016/j.jacc.2008.11.051 – ident: e_1_2_9_17_1 doi: 10.1007/s10554-013-0326-3 – ident: e_1_2_9_20_1 doi: 10.1002/ejhf.1029 – ident: e_1_2_9_23_1 doi: 10.1152/ajpheart.00843.2013 – ident: e_1_2_9_10_1 doi: 10.1186/1532-429X-14-63 – ident: e_1_2_9_13_1 doi: 10.1002/mrm.20110 – ident: e_1_2_9_6_1 doi: 10.1007/s11897-015-0267-3 |
| SSID | ssj0001561524 |
| Score | 2.3568988 |
| Snippet | Aims
While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection... While right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection... Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection... AimsWhile right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved ejection... Abstract Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co‐morbid pulmonary hypertension and heart failure with preserved... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 253 |
| SubjectTerms | Aged Cardiac Catheterization Cardiac magnetic resonance Creatinine Echocardiography Ejection fraction Female Fibrosis Fibrosis - diagnosis Fibrosis - etiology Follow-Up Studies Heart failure Heart Failure - complications Heart Failure - diagnosis Heart Failure - physiopathology Heart failure with preserved ejection fraction Heart Ventricles - diagnostic imaging Heart Ventricles - physiopathology Hemodynamics Humans Hypertension, Pulmonary - etiology Hypertension, Pulmonary - physiopathology Intubation Magnetic Resonance Imaging, Cine - methods Male Middle Aged Myocardium - pathology Original Original s Predictive Value of Tests Prospective Studies Pulmonary arteries Pulmonary hypertension Regression analysis Right ventricle Stroke Volume - physiology Variables Ventricular Function, Left - physiology Ventricular Function, Right - physiology Ventricular Remodeling |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gLAspHoCBXcAEpNHHsOD4C7WqFVE5U6s2aJGNtUOVU2d0D_x6Pk0a7YgWX3qLYspzxTGZsv3nD2AfUlcMK6jSvKkiJQiutEfI017oqCoFlbSgb-fJHubyS36_V9U6pL8KEjfTAo-DOIAQwqnYQDCEEF5kAgWAaI0Vb0IFITPPNTLazmZryg4NjkjMfqTjDlROfgzcnL7LjgSJR_6Ho8m-Q5G7wGr3P4gl7PIWN_Ms43afsAfpn7OHldDF-zPrzzrntGnncbHMCMcaTPRi4Cxvift2teec5la_ecAcdgdE5ncFyAsIS6rHl-CvCsjx3w5jtwMG3_HZ7EzQVht98FbasQwS89_45u1pc_Py2TKdaCmmjdKZSIMNrdGm0AtnmUAIGwWKu0ElEZUBQvTHt6lI3RkOJmDuHWVEYpDyPpnjBjnzv8RXjSruSrledqlopG6LEx7ZG4_K8qVXrEvbxTr62mYjGqd7FjR0pkoWltbBxLRL2fu57O9JrHOz1lZZp7kGU2PFFUBQ7KYr9n6Ik7ORuke1kp2srCm2IgU2qw81SSUl8Qjphp3NzMEC6VQGP_ZaGCEIS2ug8YS9HlZknGv5vIUIwMmF6T5n2vmS_xXerSPKtKTbOwpifotr9Qzr2YrkQ8en1fcjpDXsk6EwhItNP2NFm2OLbEHht6nfRxv4AHjYrPA priority: 102 providerName: Directory of Open Access Journals – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8QX8dvqKRF9UajXpknTgC9-3LIIJz54cG8laSe3laM92t3_30za7bq4CL6VJg1NJpP8Mpn5DcBbVIXDwtg4LQoTE4VWbNGkcapUkWUcc6spGvn8e768EN8u5eURfNzGwoz8ELPBjTQjrNek4MYOpzvSUFw5_sFvz7m8BbcptpYSN3DxY2dh8dBAhqy2PJEyln4rnPlJ-enu870dKRD3H0KbfztN_glmw260uA_3JhjJPo1yfwBH2D6EO-fTRfkj6L42zm0GZOHwzcipMVj6TM-c73U3NANrWkbprNfMmYac0xnZZBk5xpIXZM3wV3DTapnrx-gHZtqa3Wyu_cz1w8ZW_gjbBwf4rn0MF4uzn1-W8ZRbIa6kSmRsSBErlWsljahTkxv0SBFTiU4gSm045R9Tzuaq0srkiKlzmGSZRor7qLIncNx2LT4DJpXL6brVyaIWoiKKfKwtapemlZW1i-DddnzLaiIep_wX1-VImcxLkkUZZBHBm7nuzUi3cbDWZxLTXIMossOLrr8qJ40rje-PtM74FdSj0oQbjkZXWvA6I0taEcHJVsjlpLdDyTOliZFNyMPFQgpB_EIqgtdzsVdIumUxLXYbasIPEldapRE8HafM_KN-vfOIQYsI1N5k2uvJfknbrALptyKsnPg234dp94_RKc-WCx6env9P5Rdwl5MtIXikn8Dxut_gSw-41vZV0Kvf9U8mMg priority: 102 providerName: Wiley-Blackwell |
| Title | Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fehf2.12565 https://www.ncbi.nlm.nih.gov/pubmed/31903694 https://www.proquest.com/docview/2379681245 https://www.proquest.com/docview/2454471697 https://www.proquest.com/docview/2333927971 https://pubmed.ncbi.nlm.nih.gov/PMC7083501 https://doaj.org/article/a9915bfa37654002a2ea9c942d320058 |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_WFsZexr7nrgsa28sGXmNZsqynsW4JYdBSxgp5M7J9ajKKndnJQ__76WTHa1jom7GEse5D-ul0-h3AB1SpxdTkYZSmJiQKrTBHE4WRUmkcc0xyTbeRzy-S2ZX4MZfzPuDW9mmV2znRT9RlXVCM_JQLKQRRu6gvqz8hVY2i09W-hMYBHHnqMmfPaq7-xVgcOJBcDKyk_BQXln92azqtJXfWIU_Xvw9j_p8qeRfC-jVo-gQe9-CRfe20_RQeYPUMHp73x-PPof6-tHbTIvNbbkapjD6-Zxpm3ba4bpctW1aMilivmTVLSklnFIlllA5LuY8lw98-OatitunuPDBTlWy1uXECMM0tW7iNa-PT3uvqBVxNJ7--zcK-okJYSDWWoSH3K5QTojSijExi0OFDjCRagSi14VR1TNk8UYVWJkGMrMVxHGuk2x5F_BIOq7rC18CksgkdslqZlkIURIyPZY7aRlGRy9IG8HEr36zo6cap6sVN1hEl84x0kXldBPB-6LvqSDb29jojNQ09iBjbv6ib66z3s8y48cjcGjdvOiw65oaj0YUWvIwpfpYGcLJVctZ7a5vxWGniYRNyf_NgegG8G5qdG9LZiqmw3tAnnJC40ioK4FVnMsOPulnO4QQtAlA7xrQzkt2WarnwVN-KEPLYffOTN7t7pJNNZlPun47vH8MbeMQpZuAzz0_gcN1s8K0DVut8BAdcXI68D43g6Gxycflz5IMUfwGbmidO |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFH8aQwIuiG8CA4yAA0hhjWPHyQEhYKs6tu60Sb1lTvJMg6akpK3Q_in-RvycNKyi2m23Kras2u_DPz8__x7AW1SxwVhnfhDH2icKLT9DHfiBUnEYcoyyhF4jj4-j0an4PpGTLfizegtDaZUrn-gcdVHnFCPf5UIKQdQu6vPsl09Vo-h2dVVCo1WLQ7z4bY9s808He1a-7zgf7p98G_ldVQE_l2ogfU0qmCs7kNSiCHSk0WIkDCQagSgTzanyljJZpPJE6QgxMAYHYZggvXjIQzvuDbgpQoutrP2oifoX07FgRHLRs6DyXZwa_tFiCNq7Lu17rjzAJkz7f2rmZcjs9rzhPbjbgVX2pdWu-7CF1QO4Ne6u4x9CvVcas5wjc0d8RqmTLp6oG2bsMbyel3NWVoyKZi-Y0SWlwDOK_DJKv6Vcy4LhT5cMVjHTtG8smK4KNlue2wXXzQWb2oNy49Ls6-oRnF7LWj-G7aqu8CkwqUxEl7pGxoUQORHxY5FhYoIgz2RhPHi_Wt807-jNqcrGedoSM_OUZJE6WXjwpu87a0k9Nvb6SmLqexARt_tQNz_Szq5TbecjM6Otn7bYd8A1R53kieBFSPG62IOdlZDTzjvMUx6qhHjfhNzc3Ku6B6_7Zmv2dJejK6yXNIRdJK4SFXjwpFWZ_o9ar2pxSSI8UGvKtDaT9ZaqnDpqcUWIfGDH_ODU7orVSfdHQ-5-Pbt6Dq_g9uhkfJQeHRwfPoc7nOIVLut9B7YXzRJfWFC3yF46S2Jwdt2m-xftm2BM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NTpp4QfwmMMAIeAAptHHsOHmYEKOrOsaqCTFpb5mTnGnRlJS0Fdq_yF-Fz03DKqq97a2qLbf2nc-fz3ffAbxBFRuMdeYHcax9otDyM9SBHygVhyHHKEsoG_l4FA1PxZczebYFf1a5MBRWubKJzlAXVU4-8i4XUgiidlFd04RFnPQHH6e_fKogRS-tq3IauimzUOw5urEmyeMIL3_b69xs77BvZf-W88HB989Dv6k44OdS9aSvST1zZX9EalEEOtJo8RMGEo1AlInmVJVLmSxSeaJ0hBgYg70wTJCyIfLQjnsLtpU9JXkHtvcPRiff_nl8LFSRXLQcqbyLY8M_WIRBJ9uVU9EVD9iEeP8P3LwKqN2JOLgLdxooyz4tde8ebGF5H3aOm8f6B1D1J8YsZsicA4BRYKXzNuqaGXtJr2aTGZuUjEpqz5nREwqQZ-QXZhScS5GYBcOfLlSsZKZeZmAwXRZsuriwItD1JRvba3TtgvCr8iGc3shqP4JOWZX4BJhUJqInXyPjQoicaPqxyDAxQZBnsjAevFutb5o35OdUg-MiXdI285RkkTpZePC67TtdUn5s7LVPYmp7EE23-6Kqf6TNrk-1nY_MjLZW3CLjHtccdZInghchefNiD3ZXQk4b2zFLeagSYoUTcnNzuxE8eNU2W6NALz26xGpBQ9hF4ipRgQePlyrT_lFrcy1qSYQHak2Z1may3lJOxo54XBFe79kx3zu1u2Z10oPhgLtPT6-fw0vYsds4_Xo4OnoGtzk5M1xI_C505vUCn1vEN89eNFuJwflN796_jQVrDg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffuse+right+ventricular+fibrosis+in+heart+failure+with+preserved+ejection+fraction+and+pulmonary+hypertension&rft.jtitle=ESC+Heart+Failure&rft.au=Patel%2C+Ravi+B&rft.au=Li%2C+Emily&rft.au=Benefield%2C+Brandon+C&rft.au=Swat%2C+Stanley+A&rft.date=2020-02-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2055-5822&rft.volume=7&rft.issue=1&rft.spage=254&rft.epage=264&rft_id=info:doi/10.1002%2Fehf2.12565&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-5822&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-5822&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-5822&client=summon |